ANVISA Guidelines on Participant Involvement in Clinical Trials [Regulatives / Guidelines]

posted by Rajul9  – India, 2024-11-24 19:19 (557 d 02:34 ago) – Posting: # 24296
Views: 4,670

Hi all,

I’m looking for clarification on ANVISA’s regulations regarding participant eligibility for clinical trials, particularly:

Are there restrictions, such as a required gap (e.g., 180 days) after participation in another trial or blood donation?
Where can I find this information in ANVISA’s guidelines?
What’s the best way to contact ANVISA for further clarification?
Any specific references or insights would be greatly appreciated!

Thanks!

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
436 visitors (0 registered, 436 guests [including 27 identified bots]).
Forum time: 22:53 CEST (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5